BioCentury
ARTICLE | Clinical News

Introgen preclinical data

October 8, 2007 7:00 AM UTC

In vitro, INGN 241 plus Velcade bortezomib killed ovarian cancer cells. Data were published in Cancer Gene Therapy. INGN 241 is a modified adenoviral vector encoding the MDA-7 tumor suppressor gene t...